GeneDx (NASDAQ:WGS) versus Ascendant Solutions (OTCMKTS:MYDP) Critical Analysis

GeneDx (NASDAQ:WGS) and Ascendant Solutions (OTCMKTS:MYDP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings.

Valuation and Earnings

This table compares GeneDx and Ascendant Solutions”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeneDx	$305.45 million	11.58	-$52.29 million	$0.05	2,462.20
Ascendant Solutions	N/A	N/A	N/A	N/A	N/A

Ascendant Solutions has lower revenue, but higher earnings than GeneDx.

Analyst Recommendations

This is a summary of recent recommendations and price targets for GeneDx and Ascendant Solutions, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeneDx	0	2	6	0	2.75
Ascendant Solutions	0	0	0	0	0.00

GeneDx presently has a consensus price target of $101.6250, indicating a potential downside of 17.45%. Given GeneDx’s stronger consensus rating and higher probable upside, analysts clearly believe GeneDx is more favorable than Ascendant Solutions.

Insider and Institutional Ownership

61.7% of GeneDx shares are held by institutional investors. 29.6% of GeneDx shares are held by company insiders. Comparatively, 31.6% of Ascendant Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares GeneDx and Ascendant Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GeneDx	0.39%	16.51%	9.35%
Ascendant Solutions	N/A	N/A	N/A

Summary

GeneDx beats Ascendant Solutions on 8 of the 9 factors compared between the two stocks.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

About Ascendant Solutions

Dougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.